
Rossari Biotech Q1 Profit Rises To ₹47 Crore, Revenue Up 28%
The story in brief
Rossari Biotech Ltd reported a consolidated net profit of ₹47.01 crore for the quarter ended 30 June 2026, with total income rising to ₹700.39 crore and revenue from operations hitting ₹697.20 crore. The company also approved the transfer of its entire shareholding in Rossari International Limited Company to Rossari Singapore, valued at ₹24 crore, and granted 4,000 stock options under its ESOP 2019 scheme.